The Silent Cholesterol Most People Have Never Heard Of — And Why We've Been Testing For It For Years

If you've had a routine cholesterol panel recently, there's a good chance it didn't tell you the whole story. One in five people worldwide carry a hidden, largely genetic risk factor for heart attack and stroke — and it doesn't show up on a standard lipid panel at all. It's called Lipoprotein(a), or Lp(a), and at Health Suite 110, we've been testing for it as a core part of our Heart Health Program for years, long before it became a mainstream conversation in cardiology.

What Is Lp(a), and Why Does It Matter?
Lp(a) is a cholesterol-carrying particle in your blood, and unlike LDL ("bad" cholesterol), your level is almost entirely determined by your genes rather than your diet or lifestyle. The American Heart Association notes that Lp(a) is mostly inherited, and when levels are high, it can raise the risk of heart disease and stroke.

We think of Lp(a) as a "FAST PASS" for cholesterol — it shuttles LDL particles into artery walls faster than normal, accelerating plaque buildup. It's also a small, dense, and highly inflammatory particle that raises the risk of blood clots, which is part of why it's considered an independent driver of cardiovascular disease, distinct from your regular cholesterol numbers.

The Numbers Are Bigger Than Most People Realize
According to the American Heart Association, about 1 in 5 people have high Lp(a), and a level of 125 nmol/L or higher raises heart attack and stroke risk — with risk potentially doubling at 250 nmol/L or higher. And because high Lp(a) usually causes no symptoms, most people who carry this risk have no idea it's there.

The impact isn't limited to heart attacks. The AHA points out that elevated Lp(a) contributes to clotting, inflammation, and plaque buildup in the arteries, which over time can restrict blood flow and significantly raise the risk of heart attack, stroke, aortic stenosis, and peripheral artery disease.

Why a Standard Cholesterol Panel Won't Catch It
This is the part that surprises most patients: your typical annual lipid panel does not include Lp(a). It has to be specifically ordered. The American Heart Association is now direct about this gap, recommending that every adult be tested for Lp(a) at least once in their lifetime, and calling it out as especially important for people with:

• A personal or family history of premature heart disease (before age 55 in men, before 65 in women)
• A known family history of high Lp(a)
• A diagnosis of familial hypercholesterolemia

If your Lp(a) does come back high, the AHA also recommends cascade screening — testing close family members, since the trait runs in families and often goes undetected for generations.

Why We've Been Ahead of the Curve
This is exactly the kind of gap our Heart Health Program was built to close. Long before Lp(a) testing became a widely recommended standard, we were already incorporating it into our advanced cardiovascular lab work for patients, alongside other markers that a routine physical simply doesn't cover — Apolipoprotein B, inflammatory markers like hs-CRP and Lp-PLA2, and carotid intima-media thickness (CIMT) ultrasound to directly visualize early plaque in the arteries.

Our philosophy has always been about early detection over damage control. We believe Lp(a) is a big piece of that puzzle — since 18% of patients with premature coronary artery disease have elevated Lp(a), and it's considered the strongest single inherited risk factor for early arterial blockages. If a parent has high Lp(a), their child has roughly a 50% chance of inheriting it — which is exactly why we treat this as a family conversation, not just an individual one.

What Happens If Your Lp(a) Comes Back High?
Here's the honest, important nuance: there's currently no approved medication specifically designed to lower Lp(a) itself. But that doesn't mean nothing can be done. What we know works is aggressively managing every other modifiable risk factor — LDL cholesterol, blood pressure, blood sugar, sleep apnea, and inflammation — because doing so has been shown to meaningfully cut cardiovascular risk even in people with genetically elevated Lp(a).

For some patients — particularly postmenopausal women — we also discuss options like hormone therapy or low-dose aspirin, both of which have shown promise in lowering Lp(a) levels or offsetting its clotting risk in select cases.

This is exactly why knowing your number matters, even without a magic pill to fix it: it changes how aggressively you and your care team manage everything else.

The Bottom Line
Lp(a) is common, largely invisible, and almost entirely genetic — which means willpower and diet alone can't protect you from it. The only way to know where you stand is a simple blood test that most providers still aren't ordering by default.
​
At Health Suite 110, testing for Lp(a) has been a standard part of our Heart Health Program for years — not because it just became trendy, but because we've long believed that finding hidden cardiovascular risk early is one of the most valuable things a primary care relationship can offer. If you don't know your Lp(a) number, it's worth asking for it at your next visit.

This blog is for educational purposes and is not a substitute for individualized medical advice. Talk to your Health Suite 110 physician about whether Lp(a) testing is right for you.

References

1. American Heart Association. Lipoprotein(a)
2. Health Suite 110. Heart Health Program
3. Health Suite 110. Advanced Cardiovascular Labs